AdaptHealth (AHCO) Stock Trades Up, Here Is Why

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

AHCO Cover Image

What Happened?

Shares of healthcare services provider AdaptHealth Corp. (NASDAQ: AHCO) jumped 2.5% in the morning session after an analyst at Truist Securities reiterated a Buy rating and a $14.00 price target on the stock. 

The analyst expressed continued confidence in the company following recent meetings with its management. The reaffirmed positive outlook and the $14 price target, which suggests a significant potential upside from its recent trading price, appear to have bolstered investor sentiment.

The shares were trading at $9.96, up 2.7% from the previous close.

Is now the time to buy AdaptHealth? Access our full analysis report here, it’s free.

What Is The Market Telling Us

AdaptHealth’s shares are somewhat volatile and have had 13 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The biggest move we wrote about over the last year was 4 months ago when the stock dropped 16.4% on the news that its fourth-quarter 2025 report revealed a significant loss that overshadowed a revenue beat. 

While total revenue of $846.3 million surpassed analyst expectations, investors focused on substantial profitability challenges. The company posted a GAAP loss of $0.76 per share, which starkly missed Wall Street's consensus estimate for a $0.35 profit and reversed the $0.37 profit per share reported in the same quarter of the previous year. 

Highlighting the pressure on profits, the operating margin contracted to negative 8.7% from a positive 11.4% a year ago. Additionally, adjusted EBITDA, a measure of operational profitability, came in at $163.1 million, missing analyst forecasts by over 14%.

AdaptHealth is up 3% since the beginning of the year, but at $9.96 per share, it is still trading 25.5% below its 52-week high of $13.38 from April 2026. Despite the year-to-date gain, investors who bought $1,000 worth of AdaptHealth’s shares 5 years ago would now be looking at only $337.88.

ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.

These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  238.43
+4.32 (1.85%)
AAPL  295.81
+1.51 (0.51%)
AMD  510.79
-9.06 (-1.74%)
BAC  57.62
-0.29 (-0.50%)
GOOG  348.19
+2.11 (0.61%)
META  557.69
-4.51 (-0.80%)
MSFT  371.60
-2.34 (-0.63%)
NVDA  197.88
-2.16 (-1.08%)
ORCL  156.74
-8.42 (-5.10%)
TSLA  374.36
-7.25 (-1.90%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.